Wave Life Sciences (NASDAQ:WVE) stock surged 5.81% on Tuesday, outperforming the broader market, fueled by the company's impressive fourth-quarter financial results.
The biopharmaceutical company reported a surprise profit of $0.17 per diluted share for the fourth quarter, surpassing analysts' expectations of a $0.19 loss per share. This marked a significant turnaround from the $0.15 loss per share in the year-ago quarter.
Additionally, Wave Life Sciences' revenue for the quarter soared to $83.7 million, up a staggering 188% year-over-year and significantly higher than the consensus estimate of $28.04 million. The strong revenue growth was likely a key driver behind the company's ability to swing to a profit during the quarter.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.